Tocilizumab Cuts Progression to Ventilation or Death in COVID-19

FRIDAY, Dec. 18, 2020 -- Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine. Carlos Salama,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news